| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 2.76 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This case examines the Bayer-Monsanto merger, evaluating its implications and complexities.
The paper investigates the merging of Monsanto’s seed and trait expertise with Bayer’s crop
protection goods, which resulted in the formation of the world’s largest agrochemical
participant. It delves into Bayer’s difficulties in skirting antitrust restrictions, as well as the
subsequent court disputes over Monsanto’s flagship product. It also scrutinizes the
attractiveness of Monsanto Company as an investment opportunity from a private equity
investor’s perspective.
Descrição
Palavras-chave
M&A Monsanto company Bayer ag Corporate finance Private equity
